Ascendis Pharma A (ASND) EBT Margin Growth (1y) (2015 - 2026)
Ascendis Pharma A (ASND) EBT Margin Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ascendis Pharma A |
2.75 Bn |
2.08 Bn |
268.20 Mn |
7,314.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
7,314.00 |
| Dec 31, 2025 |
664.00 |
| Sep 30, 2025 |
14,291.00 |
| Jun 30, 2025 |
28,106.00 |
| Mar 31, 2025 |
4,135.00 |
| Dec 31, 2024 |
1,856.00 |
| Sep 30, 2024 |
16,662.00 |
| Jun 30, 2024 |
-4,608.00 |
| Mar 31, 2024 |
19,232.00 |
| Dec 31, 2023 |
84,923.00 |
| Sep 30, 2023 |
76,971.00 |
| Jun 30, 2023 |
106,375.00 |
| Mar 31, 2023 |
150,811.00 |
| Dec 31, 2022 |
-74,574.00 |
| Sep 30, 2022 |
611,250.00 |
| Jun 30, 2022 |
1.18 Mn |
| Mar 31, 2022 |
660,830.00 |
| Dec 31, 2021 |
8,227.00 |
| Sep 30, 2021 |
-280,220.00 |
| Jun 30, 2021 |
-653,655.00 |
